Immune Pharmaceuticals, Inc.
(NASDAQ : IMNP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Loading IMNP News...
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
1.81%15.7814.2%$301.90m
SHPGShire PLC Sponsored ADR
-1.11%172.980.4%$213.79m
PRGOPerrigo Co. Plc
0.83%75.276.4%$143.86m
PRXLPAREXEL International Corporation
-0.36%86.807.9%$136.24m
MNKMallinckrodt Plc
2.12%46.3317.7%$126.60m
ALRAlere Inc.
-0.10%50.182.7%$93.63m
JAZZJazz Pharmaceuticals Plc
-0.43%158.802.2%$84.49m
UTHRUnited Therapeutics Corporation
-0.08%131.5913.9%$76.26m
ENDPEndo International Plc
1.63%11.848.9%$73.99m
PTLAPortola Pharmaceuticals, Inc.
46.75%56.138.9%$69.62m
HZNPHorizon Pharma plc
-1.22%11.737.6%$57.17m
AERIAerie Pharmaceuticals, Inc.
-0.45%54.808.9%$55.00m
ICPTIntercept Pharmaceuticals, Inc.
1.32%132.2922.1%$52.53m
MDCOMedicines Company
1.18%38.6022.3%$51.68m
CTLTCatalent Inc
-1.53%37.222.8%$40.04m

Company Profile

Immune Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It engages in the development and commercialization of targeted therapeutics, including mAbs nanotherapeutics and antibody drug conjugates, for the treatment of inflammatory diseases and cancer. The company acquires, develops and commercialises prescription drug products. Immune Pharmaceuticals was founded by Daniel G. Teper and Jean Elie Kadouche in March, 1993 and is headquartered in New York, NY.,0CV818-E